Literature DB >> 6099346

Neuroendocrinological study of opioid and serotoninergic systems in migraine patients.

G Bussone, A Boiardi, L La Mantia, F Frediani, A Martini, A M Di Giulio, A E Panerai.   

Abstract

PRL response to morphine in a group of migraine subjects was studied in the baseline condition and after neuroendocrinological inhibition and stimulation tests. No significant differences were found in comparison with control subjects. This demonstrated the integrity of the opioid system and serotoninergic pathways in migraine subjects.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6099346     DOI： 10.1007/bf02042625

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  15 in total

1.  Involvement of brain serotonin in the prolactin-releasing effect of opioid peptides.

Authors:  S Spampinato; V Locatelli; D Cocchi; L Vicentini; S Bajusz; S Ferri; E E Müller
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

2.  Evidence for a receptor supersensitivity following impairment of central serotoninergic activity in the rabbit.

Authors:  M O Carruba; G Nisticó; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

3.  Inhibitory role of the serotoninergic system in hypoglycaemia-induced growth hormone release in the dog.

Authors:  E E Müller; G Udeschini; C Secchi; F Zambotti; A Panerai; L Vicentini; F Cocola; P Mantegazza
Journal:  Acta Endocrinol (Copenh)       Date:  1976-05

4.  Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors.

Authors:  K Fuxe; L Agnati; B Everitt
Journal:  Neurosci Lett       Date:  1975-11       Impact factor: 3.046

5.  Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone.

Authors:  J F Bruni; D Van Vugt; S Marshall; J Meites
Journal:  Life Sci       Date:  1977-08-01       Impact factor: 5.037

6.  Slight effect of L-tryptophan on growth hormone release in normal human subjects.

Authors:  E E Müller; F Brambilla; F Cavagnini; M Peracchi; A Panerai
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

7.  5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine.

Authors:  F Sicuteri; B Anselmi; P L Del Bianco
Journal:  Psychopharmacologia       Date:  1973

8.  Morphine alters distribution of GABA in thalamus.

Authors:  Y Yoneda; K Kuriyama; E Kurihara
Journal:  Brain Res       Date:  1977-03-25       Impact factor: 3.252

9.  Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man.

Authors:  H Imura; Y Nakai; T Yoshimi
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

10.  Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.

Authors:  M E Trulson; E E Eubanks; B L Jacobs
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.